Pacer Advisors
FLGT icon

Pacer Advisors’s Fulgent Genetics FLGT Stock Holding History

Pacer Advisors’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-582,853
Closed -$17.4M – 2256
2022
Q4 		$17.4M Buy
582,853
+95,645
+20% +$3.42M 0.09% 186
2022
Q3 		$18.6M Buy
487,208
+123,265
+34% +$6.18M 0.13% 125
2022
Q2 		$19.8M Buy
363,943
+62,794
+21% +$3.45M 0.15% 118
2022
Q1 		$18.8M Buy
301,149
+154,566
+105% +$10.2M 0.15% 120
2021
Q4 		$14.7M Buy
146,583
+57,941
+65% +$5.09M 0.15% 113
2021
Q3 		$7.97M Buy
88,642
+9,812
+12% +$892K 0.1% 236
2021
Q2 		$7.27M Buy
+78,830
New +$6.29M 0.1% 250

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Pacer Advisors's FLGT Position: Q1 2023 in Review

Pacer Advisors sold out of Fulgent Genetics (FLGT) in Q1 2023, closing a stake of 582,853 shares — an estimated $17.4M sold.

Pacer Advisors first reported a position in FLGT in Q2 2021 and held it in 7 quarters. The position peaked at $19.8M in Q2 2022. 215 funds tracked by Wall St. Rank hold FLGT as of Q1 2023.

  • Pacer Advisors reported no remaining Fulgent Genetics position as of Q1 2023 after selling out during the quarter.
  • Pacer Advisors sold 582,853 Fulgent Genetics shares in Q1 2023, an estimated $17.4M.
  • Pacer Advisors first reported a position in Fulgent Genetics in Q2 2021 and held it in 7 quarters.
  • Pacer Advisors's Fulgent Genetics position peaked at $19.8M in Q2 2022.
  • 215 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2023.

Based on Pacer Advisors's 13F filing for Q1 2023, filed 2 May 2023.